Ian Marschner

15PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersArtificial life and complex adaptive systemsProbability theoryRadiation therapyStochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer.

Rachel Woodford, Sally Lord, Tom John

|Jun 02, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse.

Yu Yang Soon, Katrin Sjoquist, Ian C Marschner

|Oct 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease.

Ralph A H Stewart, Kristy P Robledo, Andrew M Tonkin

|Aug 06, 2024
Analysis of Nonconcurrent Controls in Adaptive Platform Trials: Separating Randomized and Nonrandomized Information.

Ian C Marschner, I Manjula Schou

|Jan 11, 2024
Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials.

Rachel Woodford, Deborah Zhou, Peey-Sei Kok

|Jan 11, 2024
Confidence distributions for treatment effects in clinical trials: Posteriors without priors.

Ian C Marschner

Pageof 3

Frequent Collaborators

4 joint publications

Rachel Woodford

4 joint publications

R John Simes

3 joint publications

Deborah Zhou

3 joint publications

Sarah J Lord